318 related articles for article (PubMed ID: 23707270)
21. Tanezumab for Patients with Osteoarthritis of the Knee: A Meta-Analysis.
Kan SL; Li Y; Ning GZ; Yuan ZF; Chen LX; Bi MC; Sun JC; Feng SQ
PLoS One; 2016; 11(6):e0157105. PubMed ID: 27294371
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and Safety of Tanezumab on Osteoarthritis Knee and Hip Pains: A Meta-Analysis of Randomized Controlled Trials.
Chen J; Li J; Li R; Wang H; Yang J; Xu J; Zha Z
Pain Med; 2017 Feb; 18(2):374-385. PubMed ID: 28034979
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain.
Kivitz AJ; Gimbel JS; Bramson C; Nemeth MA; Keller DS; Brown MT; West CR; Verburg KM
Pain; 2013 Jul; 154(7):1009-21. PubMed ID: 23628600
[TBL] [Abstract][Full Text] [Related]
24. A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee: response.
Spierings ELH; Fidelholtz J; Wolfram G; Smith MD; Brown MT; West CR
Pain; 2014 Nov; 155(11):2432-2433. PubMed ID: 25194672
[No Abstract] [Full Text] [Related]
25. Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies.
Miki K; Ohta M; Abe M; Yoshimatsu H; Fujii K; Ebata N; West CR; Brown MT; Pixton G; Isogawa N
Pain Ther; 2022 Sep; 11(3):827-844. PubMed ID: 35538185
[TBL] [Abstract][Full Text] [Related]
26. CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial.
Jin Y; Smith C; Monteith D; Brown R; Camporeale A; McNearney TA; Deeg MA; Raddad E; Xiao N; de la Peña A; Kivitz AJ; Schnitzer TJ
Osteoarthritis Cartilage; 2018 Dec; 26(12):1609-1618. PubMed ID: 30240937
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of tanezumab, NSAIDs, and placebo in patients with moderate to severe hip or knee osteoarthritis and a history of depression, anxiety, or insomnia: post-hoc analysis of phase 3 trials.
Mease P; Kuritzky L; Wright WL; Mallick-Searle T; Fountaine R; Yang R; Sadrarhami M; Faison W; Johnston E; Viktrup L
Curr Med Res Opin; 2022 Nov; 38(11):1909-1922. PubMed ID: 35980115
[No Abstract] [Full Text] [Related]
28. Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-to-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study.
Sanga P; Katz N; Polverejan E; Wang S; Kelly KM; Haeussler J; Thipphawong J
Arthritis Rheumatol; 2017 Apr; 69(4):763-773. PubMed ID: 27748055
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of twice daily sustained-release paracetamol formulation for osteoarthritis pain of the knee or hip: a randomized, double-blind, placebo-controlled, twelve-week study.
Reed K; Collaku A; Moreira S
Curr Med Res Opin; 2018 Apr; 34(4):689-699. PubMed ID: 29239664
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of Various Dosages and Administration Methods of Tanezumab for the Treatment of Pain in Knee and Hip Osteoarthritis: a Network Meta-Analysis.
Cai YZ; Nie LY; Ruan JQ; Zhao K
Clin Ther; 2021 Dec; 43(12):2116-2126. PubMed ID: 34819241
[TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind, placebo-controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis.
Prior MJ; Harrison DD; Frustaci ME
Curr Med Res Opin; 2014 Nov; 30(11):2377-87. PubMed ID: 25121804
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis.
Birbara C; Dabezies EJ; Burr AM; Fountaine RJ; Smith MD; Brown MT; West CR; Arends RH; Verburg KM
J Pain Res; 2018; 11():151-164. PubMed ID: 29386912
[TBL] [Abstract][Full Text] [Related]
33. Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain.
Schnitzer TJ; Lane NE; Birbara C; Smith MD; Simpson SL; Brown MT
Osteoarthritis Cartilage; 2011 Jun; 19(6):639-46. PubMed ID: 21251985
[TBL] [Abstract][Full Text] [Related]
34. WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee.
Conaghan PG; Dworkin RH; Schnitzer TJ; Berenbaum F; Bushmakin AG; Cappelleri JC; Viktrup L; Abraham L
J Rheumatol; 2022 Jun; 49(6):615-621. PubMed ID: 35232805
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of E-OA-07 in moderate to severe symptoms of osteoarthritis: a double-blind randomized placebo-controlled study.
Kulkarni MP; Shakeel A; Shinde BS; Rosenbloom RA
Am J Ther; 2011; 18(2):170-7. PubMed ID: 21317618
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study.
Altman R; Hochberg M; Gibofsky A; Jaros M; Young C
Curr Med Res Opin; 2015 Dec; 31(12):2331-43. PubMed ID: 26503347
[TBL] [Abstract][Full Text] [Related]
38. A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis.
Kotevoglu N; Iyibozkurt PC; Hiz O; Toktas H; Kuran B
Rheumatol Int; 2006 Feb; 26(4):325-30. PubMed ID: 15959784
[TBL] [Abstract][Full Text] [Related]
39. Predicting Treatment Responses in Patients With Osteoarthritis: Results From Two Phase III Tanezumab Randomized Clinical Trials.
Colloca L; Dworkin RH; Farrar JT; Tive L; Yang J; Viktrup L; Dasic G; West CR; Whalen E; Brown MT; Gilbert SA; Verburg KM
Clin Pharmacol Ther; 2023 Apr; 113(4):878-886. PubMed ID: 36621827
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of fulranumab as monotherapy in patients with moderate to severe, chronic knee pain of primary osteoarthritis: a randomised, placebo- and active-controlled trial.
Mayorga AJ; Wang S; Kelly KM; Thipphawong J
Int J Clin Pract; 2016 Jun; 70(6):493-505. PubMed ID: 27238963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
